Beta Bionics, Inc. · NASDAQ:BBNX
Hopman Mark sold 775 Beta Bionics, Inc. shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 15, 2026
On Sep 14, 2026, Hopman Mark (Chief Commercial Officer) sold 775 Beta Bionics, Inc. shares at US$15.52 for US$12,028 under a trading plan, leaving 86,382 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 775 shares
- Price
- US$15.52
- Value
- US$12,028
- Holding after
- 86,382 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Sale | 775 | US$15.52 | 86,382 | Direct |
Source
Related
- Beta Bionics, Inc.
- Hopman Mark
- Beta Bionics, Inc. shareholders
- Form 4 · Hopman Mark · Oct 16, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026
- Form 4 · Hopman Mark · Sep 17, 2026
- Form 4 · Hopman Mark · Sep 10, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4 · Mensinger Mike · Sep 17, 2026
- Form 4 · Saint Sean · Sep 4, 2026
- Form 4 · Hopman Mark · Sep 3, 2026